Author: SHEA
Date Published:10/13/2015 9:24:00 AM
Publication Format:

For Immediate Release: October 13, 2015
Society for Healthcare Epidemiology of America
Contact: Tamara Moore / / 202-745-5114
Author contact: Samiha Khanna / / 919-419-5069

Drug-Resistant E.coli Bacteria Increasingly Found in Community Hospitals

NEW YORK (October 13, 2015) –  The number of infections caused by highly antibiotic-resistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) bacteria is increasing in community hospitals, a setting in which most Americans receive care, according to a new study published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

“The lack of active screening for ESBL-producing bacteria in the majority of American hospitals means that infection prevention measures, such as contact isolation and patient cohorting, are not applied to patients who do not have symptoms, but who may be colonized with the bacteria,” said Joshua Thaden, MD, PhD, a lead author of the study and fellow in the division of Infectious Diseases at Duke University Medical Center. “These ‘silently’ colonized patients increase the risk of transmission to vulnerable patients via healthcare workers or environmental contamination, compromising safety and quality of care.”

Examining health records at 26 community hospitals in the southeastern U.S. between 2009 and 2014, researchers found that the incidence of ESBL-E. coli increased from 5.28 to 10.5 infections per 100,000 patients during that period. The number of hospitals reporting these infections also increased from 17 to 20.

“The fact that most healthcare-associated bacterial transmission events go unnoticed also means that the actual rate of bacterial acquisition may be much higher than our data suggest,” said Thaden.

Researchers found that the incidence of these particular infection strains continues to grow and surpass the presence of other bacteria, such as ESBL-producing Klebsiella pneumoniae.  While the infection rate of ESBL-E. coli increased at community hospitals and health care facilities, the rate of hospital-onset infections has remained virtually unchanged.

Overall, the majority of infections caused by ESBL-E.coli occurred after exposure to the healthcare system, with nearly three-quarters of the infections either hospital-onset or healthcare-associated, making these settings focal points of transmissions. However, the study also shows a concerning rise in community-associated infections in individuals with less exposure to the healthcare system.

The retrospective study used surveillance data from the Duke Infection Control Outreach Network (DICON), and followed an earlier study of 16 hospitals that had demonstrated the emergence and rise of ESBL-E.coli infections.


Joshua Thaden, Vance Fowler, Daniel Sexton, Deverick Anderson. “Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.” Web (October 13, 2015).

About ICHE
Published through a partnership between the Society for Healthcare Epidemiology of America and Cambridge University Press, Infection Control &  Hospital Epidemiology provides original, peer-reviewed scientific articles for anyone involved with an infection control or epidemiology program in a hospital or healthcare facility. ICHE is ranked 13th out of 158 journals in its discipline in the latest Web of Knowledge Journal Citation Reports from Thomson Reuters.

SHEA is a professional society representing physicians and other healthcare professionals around the world with expertise and passion in healthcare epidemiology, infection prevention, and antimicrobial stewardship. SHEA's mission is to prevent and control healthcare-associated infections, improve the use of antibiotics in healthcare settings, and advance the field of healthcare epidemiology. SHEA improves patient care and healthcare worker safety in all healthcare settings through the critical contributions of healthcare epidemiology and improved antibiotic use. The society leads this specialty by promoting science and research, advocating for effective policies, providing high-quality education and training, and developing appropriate guidelines and guidance in practice. Visit SHEA online at, and @SHEA_Epi.

About Cambridge Journals
Cambridge University Press publishes over 350 peer-reviewed academic journals across a wide spread of subject areas, in print and online. Many of these journals are leading academic publications in their fields and together form one of the most valuable and comprehensive bodies of research available today.

For further information about Cambridge Journals, visit

About Cambridge University Press
Cambridge University Press is part of the University of Cambridge. It furthers the University’s mission by disseminating knowledge in the pursuit of education, learning and research at the highest international levels of excellence.

Its extensive peer-reviewed publishing lists comprise 45,000 titles covering academic research, professional development, over 350 research journals, school-level education, English language teaching and bible publishing.

Playing a leading role in today’s international market place, Cambridge University Press has more than 50 offices around the globe, and it distributes its products to nearly every country in the world.

For further information about Cambridge University Press, visit